Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: silicon dioxide; purified water; aluminium magnesium silicate; macrogol 8000; iron oxide red; hypromellose; hyprolose; magnesium stearate; powdered cellulose; iron oxide yellow; purified talc; calcium hydrogen phosphate; titanium dioxide; croscarmellose sodium - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: magnesium stearate; silicon dioxide; purified talc; iron oxide yellow; iron oxide red; powdered cellulose; hypromellose; macrogol 8000; calcium hydrogen phosphate; hyprolose; croscarmellose sodium; aluminium magnesium silicate; purified water; titanium dioxide - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 320.001 mg - tablet - excipient ingredients: magnesium stearate; macrogol 8000; powdered cellulose; croscarmellose sodium; hypromellose; aluminium magnesium silicate; silicon dioxide; iron oxide yellow; hyprolose; purified talc; titanium dioxide; purified water; calcium hydrogen phosphate - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 320 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; iron oxide yellow; crospovidone; sodium starch glycollate; colloidal anhydrous silica; hypromellose; purified talc; macrogol 4000; iron oxide red - exforge is indicated for the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); valsartan, quantity: 160 mg - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; microcrystalline cellulose; colloidal anhydrous silica; hypromellose; purified talc; iron oxide yellow; macrogol 4000; titanium dioxide - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - valsartan, quantity: 80 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet, film coated - excipient ingredients: microcrystalline cellulose; magnesium stearate; colloidal anhydrous silica; crospovidone; hypromellose; purified talc; iron oxide yellow; macrogol 4000; titanium dioxide - treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: magnesium stearate; powdered cellulose; purified talc; hyprolose; iron oxide yellow; calcium hydrogen phosphate; iron oxide red; hypromellose; macrogol 8000; silicon dioxide; titanium dioxide; purified water; aluminium magnesium silicate; croscarmellose sodium - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: purified talc; purified water; iron oxide yellow; croscarmellose sodium; powdered cellulose; titanium dioxide; calcium hydrogen phosphate; silicon dioxide; magnesium stearate; iron oxide red; hyprolose; aluminium magnesium silicate; macrogol 8000; hypromellose - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 160.001 mg - tablet - excipient ingredients: purified talc; iron oxide yellow; hyprolose; aluminium magnesium silicate; magnesium stearate; hypromellose; purified water; iron oxide red; powdered cellulose; titanium dioxide; calcium hydrogen phosphate; silicon dioxide; croscarmellose sodium; macrogol 8000 - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 10 mg; valsartan, quantity: 320.001 mg - tablet - excipient ingredients: purified water; hyprolose; calcium hydrogen phosphate; purified talc; macrogol 8000; croscarmellose sodium; aluminium magnesium silicate; powdered cellulose; magnesium stearate; iron oxide yellow; titanium dioxide; hypromellose; silicon dioxide - the treatment of hypertension. treatment should not be initiated with this fixed dose combination.